Pharsight

Drugs that contain Lidocaine; Tetracaine

1. Pliaglis patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5919479 TARO Noninvasive dermal anesthetics
Jul, 2015

(8 years ago)

US6528086 TARO Methods and apparatus for drug delivery involving phase changing formulations
Sep, 2019

(4 years ago)

US10751305 TARO Solid-forming topical formulations for pain control
Jan, 2031

(6 years from now)

US10350180 TARO Solid-forming local anesthetic formulations for pain control
Jan, 2031

(6 years from now)

US10603293 TARO Solid-forming local anesthetic formulations for pain control
Jan, 2031

(6 years from now)

Market Authorisation Date: 29 June, 2006

Treatment: NA

Dosage: CREAM;TOPICAL

More Information on Dosage

PLIAGLIS family patents

Family Patents

2. Synera patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6546281 GALEN SPECIALTY Integrated apparatus for controlled heat aided dermal drug delivery
Jul, 2015

(8 years ago)

US6780426 GALEN SPECIALTY Method and apparatus for improved heat controlled administration of pharmaceuticals
Jul, 2015

(8 years ago)

US6306431 GALEN SPECIALTY Apparatus for heating to a desired temperature for improved administration of pharmaceutically active compounds
Jul, 2015

(8 years ago)

US5919479 GALEN SPECIALTY Noninvasive dermal anesthetics
Jul, 2015

(8 years ago)

US6465006 GALEN SPECIALTY Method for facilitating absorption of pharmaceutically active compounds
Jul, 2015

(8 years ago)

US5658583 GALEN SPECIALTY Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
Jul, 2015

(8 years ago)

US6465709 GALEN SPECIALTY Exothermic bandage
Jul, 2020

(3 years ago)

Market Authorisation Date: 23 June, 2005

Treatment: NA

Dosage: PATCH;TOPICAL

More Information on Dosage

SYNERA family patents

Family Patents